BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| yogurt - Akkermansia |
📓
Lactobacillus acidophilus LA5 improves saturated fat-induced obesity mouse model through the enhanced intestinal Akkermansia muciniphila. Scientific reports (Sci Rep ) Vol: 11 Issue 1 Pages: 6367 Pub: 2021 Mar 18 Epub: 2021 Mar 18 Authors Ondee T , Pongpirul K , Visitchanakun P , Saisorn W , Kanacharoen S , Wongsaroj L , Kullapanich C , Ngamwongsatit N , Settachaimongkon S , Somboonna N , Leelahavanichkul A , Html Article Publication |
| yogurt - Akkermansia |
📓
Effects of daily consumption of the probiotic Bifidobacterium animalis subsp. lactis CECT 8145 on anthropometric adiposity biomarkers in abdominally obese subjects: a randomized controlled trial. International journal of obesity (2005) (Int J Obes (Lond) ) Vol: Issue Pages: Pub: 2018 Sep 27 Epub: 2018 Sep 27 Authors Pedret A , Valls RM , Calderón-Pérez L , Llauradó E , Companys J , Pla-Pagà L , Moragas A , Martín-Luján F , Ortega Y , Giralt M , Caimari A , Chenoll E , Genovés S , Martorell P , Codoñer FM , Ramón D , Arola L , Solà R , Html Article Publication |
| yogurt - Akkermansia |
📓
Strategies to promote abundance of <i>Akkermansia muciniphila</i>, an emerging probiotics in the gut, evidence from dietary intervention studies. Journal of functional foods (J Funct Foods ) Vol: 33 Issue Pages: 194-201 Pub: 2017 Jun Epub: 2017 Mar 29 Authors Zhou K , Html Article Publication |
| yogurt - Akkermansia |
📓
Enterococcus faecium GEFA01 alleviates hypercholesterolemia by promoting reverse cholesterol transportation via modulating the gut microbiota-SCFA axis. Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 1020734 Pub: 2022 Epub: 2022 Nov 8 Authors Xu W , Zou K , Zhan Y , Cai Y , Zhang Z , Tao X , Qiu L , Wei H , Html Article Publication |
| yogurt - Akkermansia |
📓
Postbiotics Prepared Using Lactobacillus paracasei CCFM1224 Prevent Nonalcoholic Fatty Liver Disease by Modulating the Gut Microbiota and Liver Metabolism. International journal of molecular sciences (Int J Mol Sci ) Vol: 23 Issue 21 Pages: Pub: 2022 Nov 4 Epub: 2022 Nov 4 Authors Pan Z , Mao B , Zhang Q , Tang X , Yang B , Zhao J , Cui S , Zhang H , Html Article Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
